EQT Foundation Supports Hong Kong Healthtech Innovator Syngular in Revolutionizing Surgical Precision with AI and XR

EQT Foundation Supports Hong Kong Healthtech Innovator Syngular in Revolutionizing Surgical Precision with AI and XR

(IN BRIEF) EQT Foundation has invested €100,000 in Syngular Technology, a Hong Kong-based startup developing an AI- and AR-powered surgical guidance platform. The company’s system integrates extended reality and artificial intelligence to deliver real-time, spatially aware surgical support that enhances precision and reduces operating time. Having been used in more than 80 surgeries, including pilots with the Hong Kong Hospital Authority, Syngular aims to expand its reach and address the growing need for advanced surgical navigation tools. The investment, part of EQT’s Impact Challenge initiative, will support Syngular’s mission to transform operating rooms through intelligent, immersive technology that improves both surgical efficiency and patient outcomes.

(PRESS RELEASE) STOCKHOLM, 20-Oct-2025 — /EuropaWire/ — EQT Foundation has announced its investment in Syngular Technology, a Hong Kong-based healthtech startup pioneering an AI- and AR-powered surgical guidance platform designed to enhance precision and efficiency in operating rooms. The investment, made through a €100,000 SAFE (Simple Agreement for Future Equity), follows Syngular’s win in the EQT Impact Challenge in Hong Kong, recognizing its potential to transform surgical care through immersive technology and intelligent automation.

Syngular’s innovative platform integrates augmented reality overlays with AI-based anatomical segmentation and digital twin generation, enabling surgeons to visualize and navigate complex anatomy in real time. By merging extended reality (XR), gaming technology, and machine learning, the system provides spatial guidance directly during surgery—reducing preparation time, enhancing surgical accuracy, and lowering the risk of complications. This capability is especially significant for hospitals facing resource constraints, where advanced surgical tools are often unavailable or limited.

One of the core challenges in modern surgery is the lack of real-time navigational assistance. Surgeons frequently rely on 2D images and memory when performing high-risk procedures, resulting in longer operation times and higher costs. Syngular’s technology directly addresses this gap by offering fully immersive, spatially aware guidance that has already been applied in over 80 clinical cases, including collaborations with the Hong Kong Hospital Authority.

“Our mission is to revolutionize how medical professionals learn and operate through the convergence of AI and XR,” said Louis Sze, CEO and Co-Founder of Syngular Technology. “This partnership with EQT Foundation will help us scale our platform to meet the growing clinical demand and extend our reach across Hong Kong and beyond.”

Cilia Holmes Indahl, CEO of EQT Foundation, added, “Syngular Technology is a powerful example of how frontier technology can be applied to solve pressing healthcare challenges. Their platform makes surgical innovation both practical and impactful, bringing tangible benefits to patient outcomes and hospital efficiency.”

With a founding team experienced in medical imaging, 3D modeling, and interactive game design—drawing talent from Medtronic, Nvidia, EA, Riot Games, and Oracle—Syngular is strategically expanding through partnerships with medical education institutions and B2B channels. The company’s next phase focuses on strengthening its footprint within Hong Kong’s healthcare system while preparing for regional expansion across Asia.

Media contact:

EQT Press Office
press@eqtpartners.com
+46 8 506 55 334

About EQT
EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of more than three decades of developing companies across multiple geographies, sectors and strategies. EQT has investment strategies covering all phases of a business’ development, from start-up to maturity. EQT has €‌​​267​‌ billion in total assets under management (€139​‌ billion in fee-generating assets under management) as of 30 September 2025, within two business segments – Private Capital and Real Assets.

With its roots in the Wallenberg family’s entrepreneurial mindset and philosophy of long-term ownership, EQT is guided by a set of strong values and a distinct corporate culture. EQT manages and advises funds and vehicles that invest across the world with the mission to future-proof companies, generate attractive returns and make a positive impact with everything EQT does.

The EQT AB Group comprises EQT AB (publ) and its direct and indirect subsidiaries, which include general partners and fund managers of EQT funds as well as entities advising EQT funds. EQT has offices in more than 25 countries across Europe, Asia and the Americas and has more than 1,900 employees.

More info: www.eqtgroup.com
Follow EQT on LinkedIn, X, YouTube and Instagram

About EQT Foundation
EQT Foundation is a philanthropic organization and long-term shareholder of the global investment organization EQT, founded by partners at EQT. The Foundation supports scientists and entrepreneurs bringing breakthrough solutions from lab to market, combining EQT’s expertise with catalytic investments and grants. With a focus on supporting scientific progress in underfunded areas of climate and health, the Foundation provides a learning platform for EQT employees to develop and work collaboratively across the globe, while engaging in philanthropy and making a positive impact.

EQT Foundation LinkedIn

About Syngular Technology
Hong Kong Syngular Technology Limited is an innovative MedTech startup committed to advancing surgical precision and patient safety through cutting-edge AI and Extended Reality (XR) solutions. Our proprietary platform enables automated, patient-specific medical image modeling and XR based surgical navigation. By leveraging the convergence of advanced AI medical image processing, spatial computing, and advanced game technology, we deliver immersive, AAA-grade experiences that enhance the accuracy, speed, and safety of surgical procedures. Our technology is designed to be accessible to less technical users and offers a cost-effective alternative to traditional surgical robotic systems, aiming to democratize advanced surgical capabilities and improve healthcare outcomes worldwide.

SOURCE: EQT AB